ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,444Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 395

$541K Total Retail Price of All Prescriptions

Rank: 75 out of 395

359 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

17% of this provider’s 359 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 359 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
NAMENDA 754 690 43 1 45
RISPERIDONE 680 477 42 A 2 72
QUETIAPINE FUMARATE 620 314 42 A 3 79
DONEPEZIL HCL 483 465 31 4 36
LISINOPRIL 458 355 53 5 1
AMLODIPINE BESYLATE 417 324 48 6 4
LEVOTHYROXINE SODIUM 392 360 38 7 3
FUROSEMIDE 376 331 40 8 10
METOPROLOL TARTRATE 343 253 43 9 11
LOVASTATIN 274 196 14 10 17
OMEPRAZOLE 246 197 50 11 6
HYDROCODONE-ACETAMINOPHEN 241 171 69 S3 12 5
DIVALPROEX SODIUM 219 149 19 13 107
CARVEDILOL 190 147 32 14 23
SIMVASTATIN 187 150 28 15 2
JANTOVEN 181 <11 <11 16 119
CLOPIDOGREL 158 86 19 17 21
TAMSULOSIN HCL 157 141 19 18 24
CYMBALTA 145 93 12 19 75
HEPARIN SODIUM 143 96 17 20 159
TEMAZEPAM 137 123 19 B 21 33
OXYCONTIN 136 <11 <11 S2 22 203
ATORVASTATIN CALCIUM 136 94 27 22 8
LEVETIRACETAM 132 70 13 24 105
IPRATROPIUM BROMIDE 129 65 11 25 116
CLONIDINE HCL 126 69 20 26 60
LOXAPINE 124 <11 <11 A 27 192
METFORMIN HCL 123 <11 <11 28 7
BENZTROPINE MESYLATE 121 <11 <11 R 29 179
CITALOPRAM HBR 116 43 13 30 26
GABAPENTIN 111 91 28 31 12
ALBUTEROL SULFATE 109 74 14 32 110
SUCRALFATE 107 59 13 33 250
PANTOPRAZOLE SODIUM 104 75 23 34 35
HYDRALAZINE HCL 102 71 24 35 61
NOVOLIN R 99 71 19 36 154
KLOR-CON M20 97 86 11 37 134
LANTUS 96 <11 <11 38 91
XARELTO 93 49 14 39 175
GLYBURIDE 91 42 11 R 40 117
GLIPIZIDE 90 <11 <11 41 32
OXYCODONE HCL-ACETAMINOPHEN 87 25 15 S2 42 48
PAROXETINE HCL 86 <11 <11 43 69
FLUOXETINE HCL 85 <11 <11 44 44
CEFEPIME HCL 85 <11 <11 10 44 194
ALPRAZOLAM 83 78* 18 B 46 14
SERTRALINE HCL 83 <11 <11 46 31
VIMPAT 82 <11 <11 48 169
ESCITALOPRAM OXALATE 82 <11 <11 48 83
OXYCODONE-ACETAMINOPHEN 82 33 23 S2 48 81
OLANZAPINE 82 <11 <11 A 48 162
POTASSIUM CHLORIDE 81 47 18 52 22
GEMFIBROZIL 77 <11 <11 53 78
RANITIDINE HCL 76 <11 <11 54 37
LEVOFLOXACIN 75 53 55 55 92
CARBIDOPA-LEVODOPA 72 <11 <11 56 144
RENVELA 68 <11 <11 57 196
LORAZEPAM 67 33 24 B 58 43
TYGACIL 66 <11 <11 10 59 276
FAMOTIDINE* 64 42 15 60 70
KLOR-CON M10 64 <11 <11 60 186
LACTULOSE 61 25 12 62 142
AMIODARONE HCL 60 55* 16 63 152
BACLOFEN 59 <11 <11 64 77
IPRATROPIUM-ALBUTEROL 57 38 13 65 158
CARAFATE 57 <11 <11 65 294
SEROQUEL XR 57 <11 <11 A 65 294
FENTANYL 56 <11 <11 S2 68 136
OXYCODONE HCL 56 <11 <11 S2 68 42
CLONAZEPAM 56 42 11 B 68 66
SPIRONOLACTONE 56 <11 <11 68 76
NOVOLOG FLEXPEN 55 20 12 72 124
ENOXAPARIN SODIUM 52 <11 <11 73 150
VALPROIC ACID* 52 <11 <11 73 212
TRAMADOL HCL 51 <11 <11 75 30
MORPHINE SULFATE ER 51 <11 <11 S2 75 57
ALENDRONATE SODIUM 50 <11 <11 77 20
FINASTERIDE 50 <11 <11 77 58
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.